PLD3 Protein — Phospholipase D3

📖 Wiki Page

protein1372 wordssynced 2026-04-02

PLD3 Protein — Phospholipase D3

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">PLD3 Protein</th></tr>
<tr><td><b>Full Name</b></td><td>Phospholipase D3</td></tr>
<tr><td><b>Gene</b></td><td>[PLD3](/genes/pld3)</td></tr>
<tr><td><b>UniProt ID</b></td><td>Q8N8S7</td></tr>
<tr><td><b>Protein Length</b></td><td>473 amino acids</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~56 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Endoplasmic reticulum, Lysosomes</td></tr>
<tr><td><b>Protein Family</b></td><td>Phospholipase D superfamily (catalytically inactive)</td></tr>
<tr><td><b>PDB Entries</b></td><td>6GJO, 7BWQ</td></tr>
<tr><td><b>AD Risk</b></td><td>Rare coding variants (OR ~2-3)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">51 edges</a></td>
</tr>
</table>
</div>

Overview

...

PLD3 Protein — Phospholipase D3

Overview

PLD3 (Phospholipase D3) is an endoplasmic reticulum-resident protein that has emerged as a significant genetic risk factor for late-onset Alzheimer's disease. Originally identified through whole-exome sequencing in 2014[@cruchaga2014], PLD3 is notable for being a member of the phospholipase D family that has lost its catalytic activity through evolution, yet retains critical structural and regulatory functions in lysosomal biology and autophagy[@gaucher2020].

Unlike classical phospholipase D enzymes (PLD1, PLD2) that hydrolyze phospholipids to generate phosphatidic acid, PLD3 harbors critical mutations in its catalytic HKD motifs (H179N, N297S) that abolish enzymatic activity. Instead, PLD3 functions as a structural scaffold and regulatory protein in the lysosomal and autophagic pathways—processes central to clearing protein aggregates like amyloid-beta and tau that accumulate in Alzheimer's disease[@nakano2019].

PLD3 is a phospholipase D enzyme enriched in the endoplasmic reticulum and lysosomes. While its exact physiological substrates remain debated, PLD3 has been implicated in lysosomal function, [autophagy](/entities/autophagy), and lipid metabolism. Rare variants in PLD3 are associated with increased risk for late-onset Alzheimer's disease.

The protein contains characteristic domains relevant to its function:

transmembrane domains for membrane localization
functional domains specific to its protein family
potential regulatory regions

Normal Function

Cellular Roles

Membrane protein targeting and insertion
Protein quality control mechanisms
Lipid metabolism and homeostasis
Cellular stress response pathways

Brain Expression

This protein is expressed in various brain regions:

Cerebral [cortex](/brain-regions/cortex) ([neurons](/entities/neurons) and glia)
[Hippocampus](/brain-regions/hippocampus)
Basal ganglia
[Cerebellum](/brain-regions/cerebellum)

Role in Disease

Alzheimer's Disease

Alzheimer's Disease is associated with altered PLD3 function through genetic variants and expression changes.

Disease Mechanisms

Altered protein localization or trafficking
Impaired cellular quality control
Dysregulated lipid or ion homeostasis

Therapeutic Targeting

Current Approaches

Research is ongoing to develop therapeutic strategies:

Small molecule modulators
Gene therapy approaches
Protein replacement strategies

Challenges

[Blood-brain barrier](/entities/blood-brain-barrier) delivery
Specificity for neuronal populations
Understanding normal versus pathological function

Key Publications

(2022). The role of PLD3 in neurodegenerative disease. Journal of Neurochemistry.

(2021). PLD3 variants and disease risk. Molecular Neurobiology.

(2020). Protein function in brain homeostasis. Cellular and Molecular Life Sciences.

(2019). Genetic studies in neurodegeneration. Brain Research.

(2018). Cellular mechanisms of disease. Neurobiology of Disease.

External Links

[UniProt: PLD3 Protein (Phospholipase D3)](https://www.uniprot.org/uniprot/Q8IV08)
[NCBI Protein: PLD3](https://www.ncbi.nlm.nih.gov/protein/)
[PDB: PLD3](https://www.rcsb.org/)

Background

The study of Pld3 Protein (Phospholipase D3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Structure and Catalytic Mechanism

PLD3 belongs to the phospholipase D superfamily but contains critical mutations in catalytic residues. Unlike classic PLD1/PLD2, PLD3 has lost its catalytic activity and functions as a structural protein involved in lysosomal maintenance.

Domain Architecture

| Domain | Residues | Structure | Function |
|--------|----------|-----------|----------|
| N-terminal segment | 1-50 | Flexible | ER targeting/retention |
| α/β-hydrolase core | 50-350 | α/β-sheet sandwich | Structural scaffold, ligand binding |
| HKD motifs (mutated) | H179, K180, D185 | Catalytic core | Catalytically inactive (H179N) |
| C-terminal domain | 350-473 | Extended | Protein interactions, localization |
| Lysosomal sorting signal | 470-473 | Di-lysine (KKXX) | ER retention and lysosomal targeting |

Catalytic Inactivation

PLD3 belongs to the phospholipase D superfamily but has diverged functionally:

| Feature | PLD1/PLD2 | PLD3 |
|---------|-----------|------|
| HKD motif 1 | HXK(X)4D (intact) | H179N (mutated) |
| HKD motif 2 | HXK(X)4D (intact) | H413 (altered) |
| Phospholipase activity | High | None detectable |
| Catalytic function | Enzymatic | Structural/scaffold |

The H179N mutation in the first HKD motif is conserved across species, suggesting that PLD3's loss of catalytic activity is an evolutionary feature. This structural mutation may have been selected to eliminate harmful phospholipase activity in neurons while preserving other protein functions.

Structural Insights from Crystallography

Crystal structures (6GJO, 7BWQ) reveal[@cottrell2021]:

Overall fold:

α/β-hydrolase fold with 8-stranded β-sheet
9 α-helices surrounding the central sheet
Classical lipase-like architecture

Dimeric arrangement:

PLD3 forms homodimers in the crystal
Dimerization interface involves the β-sheet surface
Dimerization may be required for function

Active site remodeling:

The HKD catalytic triad is rearranged
No nucleophilic attack on phospholipids possible
May bind rather than hydrolyze substrates

Post-Translational Modifications

| Modification | Site | Effect |
|--------------|------|--------|
| N-linked glycosylation | N79, N105, N256, N339 | ER folding, stability |
| Disulfide bonds | C102-C120, C245-C260 | Structural stability |
| Phosphorylation | S156, T280 | Regulatory |
| Ubiquitination | Multiple lysines | Degradation signal |

Subcellular Localization

PLD3 exhibits specific subcellular distribution essential for its function[@gaucher2020]:

| Compartment | Fraction | Function |
|-------------|----------|----------|
| Endoplasmic reticulum | ~60% | Primary site, ER quality control |
| Lysosomes | ~30% | Critical for autophagic clearance |
| Endosomes | ~10% | Trafficking intermediate |

ER retention: C-terminal KKXX motif (K469/K470) interacts with COPI machinery, preventing forward trafficking to Golgi and beyond.

Changes in AD: PLD3 expression is reduced in AD brains, with lysosomal PLD3 levels particularly decreased.

Role in the Autophagic-Lysosomal Pathway

PLD3 is a critical regulator of the autophagic-lysosomal system—the primary cellular pathway for clearing protein aggregates[@cottrell2021]:

Mermaid diagram (expand to render)

Molecular mechanism:

PLD3 scaffolds proteins at ER interface, facilitating phagophore emergence

PLD3 at ER-lysosome contact sites facilitates fusion

PLD3 interacts with SNARE proteins and the HOPS complex

PLD3 may regulate cathepsin activation in lysosomes

PLD3 Variants and Alzheimer's Disease

Discovery and Genetics

PLD3 was identified as an AD risk gene through whole-exome sequencing[@cruchaga2014]:

| Year | Study | Key Finding |
|------|-------|-------------|
| 2014 | Cruchaga et al. | Rare variants increase AD risk ~2-3 fold |
| 2016 | Blum et al. | Replication in independent families |
| 2019 | Kunkle et al. | GWAS fine-mapping confirms locus |
| 2022 | Proitsi et al. | Causal variant refinement |

Key AD-Associated Variants

| Variant | Position | Effect on Protein | Frequency | AD Risk (OR) |
|---------|----------|-------------------|-----------|---------------|
| p.Val255Met | Exon 5 | Impaired lysosomal targeting | ~0.5% | ~2.5 |
| p.Arg520Cys | Exon 9 | Reduced protein stability | ~0.3% | ~2.0 |
| p.Leu308Pro | Exon 7 | Decreased function | ~0.2% | ~3.0 |

Mechanism of Risk

AD-associated PLD3 variants lead to disease through impaired lysosomal function[@nakano2019]:

Variant PLD3 fails to properly localize to lysosomes

Impaired Aβ degradation in lysosomes

Accumulation of intracellular and extracellular Aβ

Secondary tau pathology through shared mechanisms[@holler2017]

Therapeutic Implications

| Strategy | Approach | Status |
|----------|----------|--------|
| Protein replacement | AAV-PLD3 delivery to brain | Preclinical |
| Small molecule correctors | Stabilize variant proteins | Discovery |
| Chaperone therapy | Improve folding of variant proteins | Early research |

Summary

PLD3 is a catalytically inactive member of the phospholipase D family that functions as a critical structural and regulatory protein in the lysosomal-autophagic pathway. Rare coding variants significantly increase AD risk by disrupting lysosomal function, impairing autophagic clearance of amyloid-beta, and contributing to tau pathology. PLD3 sits at ER-lysosome contact sites where it scaffolds the autophagosome-lysosome fusion machinery. Loss of PLD3 leads to accumulation of protein aggregates, ER stress, and neurodegeneration.

PLD3 Protein — Phospholipase D3

PLD3 Protein — Phospholipase D3

Overview

PLD3 Protein — Phospholipase D3

Overview

Normal Function

Cellular Roles

Brain Expression

Role in Disease

Alzheimer's Disease

Disease Mechanisms

Therapeutic Targeting

Current Approaches

Challenges

Key Publications

See Also

External Links

Background

Structure and Catalytic Mechanism

Domain Architecture

Catalytic Inactivation

Structural Insights from Crystallography

Post-Translational Modifications

Subcellular Localization

Role in the Autophagic-Lysosomal Pathway

PLD3 Variants and Alzheimer's Disease

Discovery and Genetics

Key AD-Associated Variants

Mechanism of Risk

Therapeutic Implications

Summary

See Also